Anbio Biotechnology Class A Ordinary Shares (NNNN) — Analysis Summary
Anbio Biotechnology Class A Ordinary Shares (NNNN) has a market cap of $1.51B with year-over-year revenue growth of +5.6%. Net margin stands at 74.1%. The stock trades at a P/E ratio of 235.9.
Key Takeaways
- Revenue changed +5.6% year-over-year
- Net margin of 74.1%
- P/E ratio of 235.9
Compared with its sector, NNNN posted revenue growth of +5.6% and trades at a P/E of 235.9.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.